Effect of HbA1c on Stroke Risk Among Patients With Diabetes and Atrial Fibrillation
A team of investigators sought to identify the effect of glycemic control on risk for stroke among patients with atrial fibrillation.
A team of investigators sought to identify the effect of glycemic control on risk for stroke among patients with atrial fibrillation.
Investigators evaluated the safety and functional outcomes of IV alteplase in patients who have had an acute ischemic stroke and are taking NOACs.
For patients with stroke of atherothrombotic origin, hypertriglyceridemia is associated with residual vascular risk.
A team of investigators sought to determine the prevalence of thyroid disorders in patients with atrial fibrillation.
In a Japanese trial, researchers assessed the effect of endovascular therapy with medical care compared with medical care alone among patients with acute ischemic stroke and large infarctions.
Among patients with a history of ischemic stroke, more intensive LDL-C-lowering statin-based therapies are associated with a decreased risk for recurrent stroke.
About 1.7 years of more intensive hypertensive treatment would be needed to prevent one stroke per 200 older adults.
Investigators evaluated data from BETonMACE to assess a relationship between the use of insulin and risk of MACE in patients with diabetes and acute coronary syndrome.
The AHA has issued a Presidential Advisory Statement outlining considerations for addressing the effects of opioids on cardiovascular and neurovascular health.
The addition of systematic ECG monitoring to usual diagnostic care may improve the detection of atrial fibrillation in patients hospitalized with acute ischemic stroke or TIA.